We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

139 hedge funds and large institutions have $443M invested in Albany Molecular Research Inc in 2017 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 45 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

5% more funds holding

Funds holding: 133 → 139 (+6)

9% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

24% less capital invested

Capital invested by funds: $581M → $443M (-$137M)

98% less call options, than puts

Call options by funds: $1.15M | Put options by funds: $67.5M

Holders
139
Holders Change
+6
Holders Change %
+4.51%
% of All Funds
3.46%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
22
Increased
49
Reduced
45
Closed
11
Calls
$1.15M
Puts
$67.5M
Net Calls
-$66.3M
Net Calls Change
+$22.6M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$65.3M
2
ACM
American Capital Management
New York
+$12.7M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$11.4M
4
LOAMU
Lombard Odier Asset Management (USA)
New York
+$6.9M
5
FHAM
Folger Hill Asset Management
New York
+$3.9M

Top Sellers

Rank Fund Capital Flow
1
VNIM
Vaughan Nelson Investment Management
Texas
-$39.1M
2
Natixis Advisors
Natixis Advisors
Massachusetts
-$3.61M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.43M
4
CCP
Clough Capital Partners
Massachusetts
-$3.03M
5
PIP
Permian Investment Partners
Texas
-$2.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
FHAM
26
Folger Hill Asset Management
New York
$3.34M +$3.9M +237,902 New
PTC
27
Philadelphia Trust Company
Pennsylvania
$3.32M +$1.1M +67,318 +40%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$2.87M +$112K +6,853 +3%
Russell Investments Group
29
Russell Investments Group
United Kingdom
$2.78M -$310K -18,930 -9%
Principal Financial Group
30
Principal Financial Group
Iowa
$2.4M +$97.6K +5,960 +4%
Wells Fargo
31
Wells Fargo
California
$2.37M +$480K +29,338 +21%
Two Sigma Investments
32
Two Sigma Investments
New York
$2.21M +$2.59M +157,860 New
Renaissance Technologies
33
Renaissance Technologies
New York
$2.08M -$3.43M -209,558 -59%
Fisher Asset Management
34
Fisher Asset Management
Washington
$2.03M +$1.05M +63,828 +79%
Citadel Advisors
35
Citadel Advisors
Florida
$1.93M +$1.65M +100,513 +271%
MOACM
36
Mutual of America Capital Management
New York
$1.87M +$16.3K +995 +0.8%
PI
37
Putnam Investments
Massachusetts
$1.85M -$229K -13,989 -10%
RIM
38
Ranger Investment Management
Texas
$1.73M +$300K +18,310 +17%
SIP
39
Stoneridge Investment Partners
Pennsylvania
$1.66M +$1.93M +118,090 New
Ameriprise
40
Ameriprise
Minnesota
$1.65M +$36.6K +2,234 +2%
Goldman Sachs
41
Goldman Sachs
New York
$1.65M -$200K -12,236 -9%
AA
42
Ancora Advisors
Ohio
$1.6M – – –
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$1.54M +$1.4M +85,352 +350%
Deutsche Bank
44
Deutsche Bank
Germany
$1.5M -$152K -9,287 -8%
Skandinaviska Enskilda Banken (SEB)
45
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.45M +$1.7M +103,600 New
Charles Schwab
46
Charles Schwab
California
$1.42M +$86.8K +5,301 +6%
Bessemer Group
47
Bessemer Group
New Jersey
$1.28M – – –
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$1.28M -$108K -6,600 -7%
GCP
49
GSA Capital Partners
United Kingdom
$1.16M +$840K +51,300 +163%
Two Sigma Advisers
50
Two Sigma Advisers
New York
$1.11M +$1.3M +79,100 New
1
2
3 4 5

AMRI Hedge Fund Activity: Q1 2017 in Review

139 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q1 2017, worth a combined $443M — down 24% from $581M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AMRI positions and 11 closed out — a net gain of 11 holders — while 49 added to existing stakes and 45 trimmed.

The largest buyer was BlackRock, adding an estimated $65.3M. The largest seller was Vaughan Nelson Investment Management, exiting entirely with an estimated $39.1M sold.

  • 139 institutional investors held Albany Molecular Research Inc (AMRI) as of Q1 2017, up from 133 in Q4 2016.
  • Funds reported $443M of Albany Molecular Research Inc stock for Q1 2017, down 24% quarter-over-quarter.
  • 22 funds opened new Albany Molecular Research Inc positions in Q1 2017 and 11 closed out, a net change of +11 holders.
  • The largest Albany Molecular Research Inc buyer in Q1 2017 was BlackRock, an estimated $65.3M added.
  • The largest Albany Molecular Research Inc seller in Q1 2017 was Vaughan Nelson Investment Management, an estimated $39.1M sold.

Based on aggregated 13F filings for Q1 2017.